Application of polyoxymethylflavone, polyoxymethylflavone composition and polyoxymethylflavone preparation for prevention or treatment of hyperlipidemia

A polymethoxyflavonoid, hyperlipidemia technology, applied in the field of medicine, can solve problems such as elevated transaminases, acute renal failure, liver and kidney damage, etc.

Active Publication Date: 2017-02-15
CHINA PHARM UNIV
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main drugs for the treatment of hyperlipidemia are statins, fibrates, niacin, and bile acid chelating agents, etc., but long-term use of these drugs can cause elevated transaminases, which have certain damage to the liver and kidneys. In severe cases, it may cause acute renal failure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of polyoxymethylflavone, polyoxymethylflavone composition and polyoxymethylflavone preparation for prevention or treatment of hyperlipidemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0015] The technical solutions of the present invention will be described in detail below in conjunction with the embodiments.

[0016] experimental method:

[0017] 1. Establishment of animal models

[0018] Take 60 C57BL / 6 male mice, weighing 18-20 g, aged 6 weeks. After one week of adaptation, the mice were randomly divided into: normal chow diet group (Normal chow diet, NCD, also known as blank group), Western type diet group (Western type diet, WD, also known as model group), lovastatin group (Lovastatin, LOV) , HMF low-dose group (HMF-L) and HMF high-dose group (HMF-H), except the normal diet group, other groups were fed with Western-style diet. WD feed formula is: 1.25% cholesterol, 20% lard, 5% sucrose, 0.5% cholic acid, vitamins adjusted to normal levels.

[0019] 2. Administration dose and administration method: WD-induced hyperlipidemia experiment was carried out by intragastric administration in mice. Modeling began to administer, and NCD and WD were given the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of polyoxymethylflavone, a polyoxymethylflavone composition and a polyoxymethylflavone preparation for prevention or treatment of hyperlipidemia. The active ingredient of a drug for the prevention or treatment of the hyperlipidemia comprises polyoxymethylflavone, wherein the polyoxymethylflavone refers to 3,5,6,7,8,3',4'-heptamethoxyflavones, and the active ingredient further comprises pharmaceutically acceptable carriers or excipients so as to be prepared into a pharmaceutically acceptable dosage form. The high level of either of the total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL-c) of plasma can cause the hyperlipidemia. The invention confirms that 3,5,6,7,8,3',4'-heptamethoxyflavones (HMF) can significantly reduce the levels of the TG, the TC and the LDL-c, significantly increase the level of HDL-C in the plasma, and prevent or treat the hyperlipidemia.

Description

technical field [0001] The invention belongs to the field of medicine and relates to new applications of natural products, in particular to the application of polymethoxylated flavones, compositions and preparations thereof in the prevention or treatment of hyperlipidemia. Background technique [0002] Hyperlipidemia is a metabolic disease in which one or more lipids in plasma are higher than normal due to abnormal fat metabolism or operation. Atherosclerosis caused by deposits. Hyperlipidemia is closely related to cardiovascular diseases, and is the complication and predisposing factor of atherosclerosis, fatty liver, coronary heart disease, diabetes, obesity and other diseases. At present, the main drugs for the treatment of hyperlipidemia are statins, fibrates, niacin, and bile acid chelating agents, etc., but long-term use of these drugs can cause elevated transaminases, which have certain damage to the liver and kidneys. In severe cases, it may cause acute renal failu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61K31/704A61P3/06
CPCA61K31/352A61K31/704A61K2300/00
Inventor 刘鄂湖谢志深肖娉婷
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap